Teleflex Incorporated (NYSE:TFX) Receives $252.50 Consensus Target Price from Brokerages

Teleflex Incorporated (NYSE:TFX) has been given a consensus recommendation of “Moderate Buy” by the seven analysts that are covering the firm, Marketbeat reports. Three investment analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 12-month target price among brokerages that have updated their coverage on the stock in the last year is $252.50.

Several equities analysts recently issued reports on the stock. Truist Financial reduced their price target on shares of Teleflex from $227.00 to $200.00 and set a “hold” rating on the stock in a research report on Wednesday, December 18th. StockNews.com upgraded shares of Teleflex from a “hold” rating to a “buy” rating in a research report on Thursday, November 28th. Mizuho cut their price objective on shares of Teleflex from $275.00 to $250.00 and set a “neutral” rating on the stock in a report on Friday, November 1st. Royal Bank of Canada cut their price objective on shares of Teleflex from $275.00 to $245.00 and set an “outperform” rating on the stock in a report on Friday, November 1st. Finally, Needham & Company LLC restated a “hold” rating on shares of Teleflex in a report on Monday, December 16th.

Teleflex Price Performance

Shares of NYSE TFX opened at $167.44 on Thursday. Teleflex has a 1 year low of $166.76 and a 1 year high of $256.85. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39. The company’s 50-day moving average is $178.15 and its 200 day moving average is $209.23. The stock has a market capitalization of $7.78 billion, a P/E ratio of 33.29, a P/E/G ratio of 1.72 and a beta of 1.16.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in TFX. Norges Bank bought a new position in shares of Teleflex in the fourth quarter worth approximately $100,328,000. Invesco Ltd. lifted its position in Teleflex by 48.1% during the fourth quarter. Invesco Ltd. now owns 1,068,593 shares of the medical technology company’s stock valued at $190,188,000 after purchasing an additional 347,003 shares during the period. Diamond Hill Capital Management Inc. bought a new position in Teleflex during the fourth quarter valued at approximately $46,696,000. T. Rowe Price Investment Management Inc. lifted its position in Teleflex by 4.4% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 6,173,121 shares of the medical technology company’s stock valued at $1,098,693,000 after purchasing an additional 261,279 shares during the period. Finally, Magnetar Financial LLC lifted its position in Teleflex by 105.2% during the fourth quarter. Magnetar Financial LLC now owns 421,340 shares of the medical technology company’s stock valued at $74,990,000 after purchasing an additional 215,961 shares during the period. Institutional investors own 95.62% of the company’s stock.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.